Graphite Bio Future Growth
Future criteria checks 0/6
Graphite Bio is forecast to grow earnings at 36.4% per annum. EPS is expected to grow by 73.8% per annum.
Key information
36.4%
Earnings growth rate
73.8%
EPS growth rate
| Biotechs earnings growth | 23.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2023 |
Recent future growth updates
Recent updates
Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation
Sep 20
We're Hopeful That Graphite Bio (NASDAQ:GRPH) Will Use Its Cash Wisely
Jun 02Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?
Feb 01Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation
Oct 05Graphite Bio doses first patient with GPH101 for sickle cell disease
Aug 11Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?
Jun 22Graphite Bio: Selling For Much Less Than Net Cash
May 25Graphite Bio: An Important Stock To Track In The Gene Editing Space
Nov 18Graphite Bio (NASDAQ:GRPH) Is In A Good Position To Deliver On Growth Plans
Sep 25Graphite Bio: Assessing Prospects Amid Doubts Raised On Safety Of Crispr
Aug 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -23 | N/A | N/A | 1 |
| 12/31/2025 | N/A | -23 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -23 | N/A | N/A | 1 |
| 12/31/2023 | N/A | -125 | -101 | -90 | N/A |
| 9/30/2023 | N/A | -126 | -78 | -67 | N/A |
| 6/30/2023 | N/A | -129 | -87 | -79 | N/A |
| 3/31/2023 | N/A | -99 | -92 | -88 | N/A |
| 12/31/2022 | N/A | -101 | -95 | -88 | N/A |
| 9/30/2022 | N/A | -95 | -88 | -81 | N/A |
| 6/30/2022 | N/A | -85 | -84 | -74 | N/A |
| 3/31/2022 | N/A | -77 | -75 | -66 | N/A |
| 12/31/2021 | N/A | -71 | -59 | -53 | N/A |
| 9/30/2021 | N/A | -115 | -48 | -43 | N/A |
| 6/30/2021 | N/A | -104 | -32 | -30 | N/A |
| 3/31/2021 | N/A | -88 | -19 | -17 | N/A |
| 12/31/2020 | N/A | -68 | -10 | -9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GRPH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GRPH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GRPH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if GRPH's revenue is forecast to grow faster than the US market.
High Growth Revenue: GRPH is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GRPH's Return on Equity is forecast to be high in 3 years time